U.S. markets close in 6 hours 24 minutes
  • S&P 500

    3,923.33
    -2.10 (-0.05%)
     
  • Dow 30

    31,964.96
    +3.10 (+0.01%)
     
  • Nasdaq

    13,593.00
    -4.97 (-0.04%)
     
  • Russell 2000

    2,284.38
    +53.07 (+2.38%)
     
  • Crude Oil

    62.99
    -0.23 (-0.36%)
     
  • Gold

    1,780.10
    -17.80 (-0.99%)
     
  • Silver

    27.90
    -0.03 (-0.10%)
     
  • EUR/USD

    1.2225
    +0.0057 (+0.46%)
     
  • 10-Yr Bond

    1.4580
    +0.0690 (+4.97%)
     
  • GBP/USD

    1.4164
    +0.0022 (+0.16%)
     
  • USD/JPY

    106.1260
    +0.2440 (+0.23%)
     
  • BTC-USD

    51,193.72
    +1,827.73 (+3.70%)
     
  • CMC Crypto 200

    1,022.82
    +28.15 (+2.83%)
     
  • FTSE 100

    6,677.21
    +18.24 (+0.27%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

Arcturus Therapeutics Holdings Inc (ARCT) Chief Scientific Officer & COO Pad Chivukula Sold ...

GuruFocus.com
·1 min read

- By insider

Chief Scientific Officer & COO of Arcturus Therapeutics Holdings Inc (30-Year Financial, Insider Trades) Pad Chivukula (insider trades) sold 10,000 shares of ARCT on 02/01/2021 at an average price of $75.31 a share. The total sale was $753,100.


Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases. Arcturus Therapeutics Holdings Inc has a market cap of $1.99 billion; its shares were traded at around $81.060000 with and P/S ratio of 132.45. Arcturus Therapeutics Holdings Inc had annual average EBITDA growth of 14.40% over the past five years. GuruFocus has detected 2 severe warning signs with Arcturus Therapeutics Holdings Inc. .

Directors and Officers Recent Trades:

  • Chief Scientific Officer & COO Pad Chivukula sold 10,000 shares of ARCT stock on 02/01/2021 at the average price of $75.31. The price of the stock has increased by 7.64% since.

For the complete insider trading history of ARCT, click here

.This article first appeared on GuruFocus.